Valuation : Inventage Lab, Inc.

Market Cap 36TCr 26Cr 23Cr 21Cr 20Cr 37Cr 2.5TCr 37Cr 253.36Cr 98Cr 1.28TCr 99Cr 97Cr 4.13TCr P/E 2024
-11.5x
P/E 2025 -110x
Enterprise Value 35TCr 26Cr 22Cr 21Cr 19Cr 36Cr 2.46TCr 36Cr 249.57Cr 97Cr 1.26TCr 98Cr 96Cr 4.07TCr EV / Sales 2024
106x
EV / Sales 2025 356x
Free-Float
73.58%
Yield 2024 *
-
Yield 2025 -
1 day+3.28%
1 week-7.75%
Current month-5.47%
1 month-14.38%
3 months-47.35%
6 months-66.91%
Current year-68.17%
1 week 25,475
Extreme 25475
30,300
1 month 25,475
Extreme 25475
34,650
Current year 22,650
Extreme 22650
1,01,700
1 year 22,650
Extreme 22650
1,01,700
3 years 9,400
Extreme 9400
1,01,700
5 years 8,440
Extreme 8440
1,01,700
10 years 8,440
Extreme 8440
1,01,700
Manager TitleAgeSince
Chief Executive Officer 52 14/05/2015
Director of Finance/CFO 55 -
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Director/Board Member 52 14/05/2015
Director/Board Member 56 -
Director/Board Member 56 -
Date Insider Type Main position Quantity % Market Cap. Importance
08/08/25 Exercice 8,000 0.0796%
08/08/25 Exercice 10,000 0.0996%
08/08/25 Exercice 8,000 0.0796%
Change 5-day change 1-year change 3-year change Capi.($)
+3.28%-7.75%-38.11%+20.18% 26Cr
-0.88%-2.15%+54.71%+106.31% 1,02400Cr
-1.15%+2.68%+53.97%+71.50% 66TCr
-1.44%+0.38%+20.40%+73.05% 45TCr
+0.14%-0.47%+29.49%+38.56% 35TCr
-1.33%+4.72%+24.69%+45.55% 30TCr
-1.15%+0.30%-1.49%+12.31% 25TCr
-1.55%+1.11%+56.10%+70.32% 24TCr
-0.88%+1.15%-17.09%-54.39% 21TCr
-0.15%+3.65%+33.90%+96.99% 19TCr
Average -0.56%+0.44%+21.66%+48.04% 36.79TCr
Weighted average by Cap. -1.10%+0.55%+36.62%+66.22%

Financials

2024 2025
Net sales 178.29Cr 13.24L 11.39L 10.72L 10L 18.32L 12Cr 18.37L 1.27Cr 49.15L 6.41Cr 49.71L 48.63L 21Cr 293.88Cr 21.82L 18.78L 17.67L 16.14L 30.19L 21Cr 30.27L 2.09Cr 81.01L 11Cr 81.94L 80.16L 34Cr
Net income -1.7TCr -1.26Cr -1.09Cr -1.02Cr -93.34L -1.75Cr -119.16Cr -1.75Cr -12Cr -4.69Cr -61Cr -4.74Cr -4.64Cr -196.95Cr -845.84Cr -62.81L -54.05L -50.85L -46.45L -86.89L -59Cr -87.13L -6.01Cr -2.33Cr -30Cr -2.36Cr -2.31Cr -98Cr
Net Debt -2.4TCr -1.78Cr -1.53Cr -1.44Cr -1.32Cr -2.46Cr -168.01Cr -2.47Cr -17Cr -6.61Cr -86Cr -6.68Cr -6.54Cr -277.7Cr -532.71Cr -39.56L -34.04L -32.02L -29.25L -54.73L -37Cr -54.88L -3.78Cr -1.47Cr -19Cr -1.49Cr -1.45Cr -62Cr
Logo Inventage Lab, Inc.
Inventage Lab Inc is a Korea-based company principally engaged in the pharmaceutical business. The Company owns the platforms applied to the development and mass production of long-acting injections and drug delivery of genetic materials. The Company is engaged in the research, manufacture and sale of human medicines used for male pattern baldness, dementia, prostate cancer and others. It is also engaged in the research, manufacture and sale of veterinary medicines such as combination drugs, chemical castration agents and others.
Employees
73
Date Price Change Volume
04/26/04 ₩26,800.00 +3.28% 45,404
03/26/03 ₩25,950.00 -5.64% 46,502
02/26/02 ₩27,500.00 -6.78% 68,216
01/26/01 ₩29,500.00 +4.06% 31,895
31/26/31 ₩28,350.00 -2.41% 33,582
  1. Stock Market
  2. Stocks
  3. A389470 Stock